Sfoglia per Autore
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
2019 F. Conforti, L. Pala, V. Bagnardi, G. Viale, T. De Pas, E. Pagan, E. Pennacchioli, E. Cocorocchio, P.F. Ferrucci, F. De Marinis, R.D. Gelber, A. Goldhirsch
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
2019 F. Conforti, L. Pala, E. Pagan, G. Viale, V. Bagnardi, G. Peruzzotti, T. De Pas, N. Bianco, R. Graffeo, E.G. Rocco, A. Vingiani, R.D. Gelber, A.S. Coates, M. Colleoni, A. Goldhirsch
Metaplastic breast cancer: Prognostic and therapeutic considerations
2020 G. Corso, S. Frassoni, A. Girardi, E. De Camilli, E. Montagna, M. Intra, L. Bottiglieri, A. Margherita De Scalzi, D.M. Fanianos, F. Magnoni, A. Invento, A. Toesca, F. Conforti, V. Bagnardi, G. Viale, M.A. Colleoni, P. Veronesi
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
2021 F. Conforti, L. Pala, E. Pagan, V. Bagnardi, T. De Pas, P. Queirolo, E. Pennacchioli, C. Catania, E. Cocorocchio, P.F. Ferrucci, M. Saponara, G. Orsolini, P. Zagami, E. Nicolo, F. De Marinis, G. Tortora, E. Bria, S. Minucci, H. Joffe, P. Veronesi, J. Wargo, R. Rosenthal, C. Swanton, A. Mantovani, R.D. Gelber, G. Viale, A. Goldhirsch, G. Giaccone
Sex and cancer immunotherapy: Current understanding and challenges
2022 L. Pala, T. De Pas, C. Catania, G. Giaccone, A. Mantovani, S. Minucci, G. Viale, R.D. Gelber, F. Conforti
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
2022 F. Conforti, P.A. Zucali, L. Pala, C. Catania, V. Bagnardi, I. Sala, P. Della Vigna, M. Perrino, P. Zagami, C. Corti, S. Stucchi, M. Barberis, E. Guerini-Rocco, B. Di Venosa, F. De Vincenzo, N. Cordua, A. Santoro, G. Giaccone, T.M. De Pas
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML
2022 L. Nicosia, F.L. Boffo, E. Ceccacci, F. Conforti, I. Pallavicini, F. Bedin, R. Ravasio, E. Massignani, T.C.P. Somervaille, S. Minucci, T. Bonaldi
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study
2022 C.M. Lombardi, C. Specchia, F. Conforti, M.T.L. Rovere, V. Carubelli, P. Agostoni, S. Carugo, G.B. Danzi, M. Guazzi, A. Mortara, M. Piepoli, I. Porto, G. Sinagra, M. Volterrani, P. Ameri, M. Gnecchi, S. Leonardi, M. Merlo, A. Iorio, A. Bellasi, C. Canale, R. Camporotondo, F. Catagnano, L.A.D. Vecchia, M. Di Pasquale, S. Giovinazzo, G. Maccagni, M. Mapelli, D. Margonato, L. Monzo, V. Nuzzi, C. Oriecuia, L. Pala, G. Peveri, A. Pozzi, G. Provenzale, F. Sarullo, M. Adamo, D. Tomasoni, R.M. Inciardi, M. Senni, M. Metra
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
2022 F. Giugliano, P.A. Zucali, G. Galli, Z. Ballatore, C. Corti, P.T. Aliaga, J. Uliano, G. Vivanet, G. Curigliano, F. Conforti, P. Queirolo, R. Berardi, S. Manglaviti, G. Apollonio, M. Perrino, F. Borea, F. D'Antonio, M.C. Garassino, T. De Pas
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
2022 C. Corti, F. Conforti, L. Pala, C. Catania, E. Cocorocchio, P.F. Ferrucci, G. Curigliano, P. Queirolo, T. de Pas
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022 G. Corso, O. D'Ecclesiis, F. Magnoni, E. Mazzotta, F. Conforti, P. Veronesi, E. Sajjadi, K. Venetis, N. Fusco, S. Gandini
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group
2022 G. Antonarelli, C. Corti, P.A. Zucali, M. Perrino, S. Manglaviti, G. Lo Russo, G.M. Varano, P. Salvini, G. Curigliano, C. Catania, F. Conforti, T. De Pas
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers
2023 P. Zagami, A. Comandone, M. Fiore, G. Giulio Baldi, G. Grignani, B. Vincenzi, A. Gronchi, G. Antonarelli, A. Boglione, E. Pennacchioli, G. Curigliano, F. Conforti, T.M. De Pas
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study
2023 F. Conforti, L. Pala, G. Vivanet, C. Corti, C. Catania, D. Maiettini, G. Varano, B. Di Venosa, G. Curigliano, P. Salvini, R. Berardi, Z. Ballatore, T.M. De Pas
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024 C. Valenza, T.M. De Pas, A. Gaeta, G. Castellano, C. Santoro, A. Corona, G. Chiappini, G. Vivanet, D. Trapani, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Pennacchioli, G. Curigliano
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile